Android app on Google Play

Lazard Capital Starts Repros Therapeutics (RPRX) at Buy

February 5, 2013 6:40 AM EST Send to a Friend
Get Alerts RPRX Hot Sheet
Price: $13.99 -3.58%

Rating Summary:
    7 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 35 | Down: 23 | New: 13
Trade RPRX Now!
Join SI Premium – FREE
Lazard Capital initiates coverage on Repros Therapeutics (NASDAQ: RPRX) with a Buy. PT $26.00.

For an analyst ratings summary and ratings history on Repros Therapeutics click here. For more ratings news on Repros Therapeutics click here.

Shares of Repros Therapeutics closed at $11.83 yesterday.




You May Also Be Interested In


Related Categories

New Coverage

Related Entities

Lazard

Add Your Comment